TY - CHAP AU - Quinn, M. AU - Babb, P. AU - Brock, A. AU - Kirby, L. AU - Jones, J. PY - 2001 DA - 2001// BT - Cancer trends in England and Wales PB - Stationary Office CY - London ID - Quinn2001 ER - TY - JOUR AU - Alberg, A. J. AU - Samet, J. M. PY - 2003 DA - 2003// TI - Epidemiology of Lung Cancer JO - Chest VL - 123S UR - https://doi.org/10.1378/chest.123.1_suppl.21S DO - 10.1378/chest.123.1_suppl.21S ID - Alberg2003 ER - TY - JOUR AU - Samet, J. M. PY - 1993 DA - 1993// TI - The epidemiology of lung cancer JO - Chest VL - 103 UR - https://doi.org/10.1378/chest.103.1_Supplement.20S DO - 10.1378/chest.103.1_Supplement.20S ID - Samet1993 ER - TY - JOUR AU - Alifano, M. AU - Benedetti, G. AU - Trisolini, R. PY - 2004 DA - 2004// TI - Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer?: an urgent call for research JO - Chest VL - 126 UR - https://doi.org/10.1378/chest.126.2.601 DO - 10.1378/chest.126.2.601 ID - Alifano2004 ER - TY - JOUR AU - Kakkar, V. V. AU - Howe, C. T. AU - Nicolaides, A. N. AU - Renney, J. T. G. AU - Clarke, M. B. PY - 1970 DA - 1970// TI - Deep vein thrombosis of the leg. Is there a "high risk" group? JO - American Journal of Surgery VL - 120 UR - https://doi.org/10.1016/S0002-9610(70)80023-X DO - 10.1016/S0002-9610(70)80023-X ID - Kakkar1970 ER - TY - JOUR AU - Kakkar, A. K. AU - de Lorenzo, F. AU - Pineo, G. F. AU - Williamson, R. C. PY - 1998 DA - 1998// TI - Venous thrombosis and cancer JO - Baillieres Clin Haematol VL - 11 UR - https://doi.org/10.1016/S0950-3536(98)80089-9 DO - 10.1016/S0950-3536(98)80089-9 ID - Kakkar1998 ER - TY - JOUR AU - Kakkar, A. K. AU - Williamson, R. C. PY - 1999 DA - 1999// TI - Antithrombotic therapy in cancer JO - BMJ VL - 318 UR - https://doi.org/10.1136/bmj.318.7198.1571 DO - 10.1136/bmj.318.7198.1571 ID - Kakkar1999 ER - TY - JOUR AU - Lee, A. Y. AU - Levine, M. N. PY - 2003 DA - 2003// TI - Venous Thromboembolism and Cancer: Risks and Outcomes JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000047062.03282.A3 DO - 10.1161/01.CIR.0000047062.03282.A3 ID - Lee2003 ER - TY - JOUR AU - Bick, R. L. PY - 1978 DA - 1978// TI - Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management JO - Semin Thromb Hemost VL - 5 ID - Bick1978 ER - TY - JOUR AU - Johnson, M. J. AU - Sproule, M. W. AU - Paul, J. PY - 1999 DA - 1999// TI - The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer JO - Journal of Clinical Oncology VL - 11 UR - https://doi.org/10.1053/clon.1999.9023 DO - 10.1053/clon.1999.9023 ID - Johnson1999 ER - TY - JOUR AU - Levitan, N. AU - Dowlatic, A. AU - Remick, S. C. AU - Tahsilda, H. I. AU - Sivinski, L. D. AU - Beyth, R. AU - Rimm, A. A. PY - 1999 DA - 1999// TI - Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data JO - Medicine VL - 78 UR - https://doi.org/10.1097/00005792-199909000-00001 DO - 10.1097/00005792-199909000-00001 ID - Levitan1999 ER - TY - JOUR AU - Alikhan, R. AU - Cohen, A. T. AU - Combe, S. AU - Samama, M. M. AU - Desjardins, L. AU - Eldor, A. AU - Janbon, C. AU - Leizorovicz, A. AU - Olsson, C. G. AU - Turpie, A. G. PY - 2003 DA - 2003// TI - Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study JO - Blood Coagulation Fibrinolysis VL - 14 UR - https://doi.org/10.1097/00001721-200306000-00004 DO - 10.1097/00001721-200306000-00004 ID - Alikhan2003 ER - TY - JOUR AU - Buccheri, G. AU - Ferrigno, D. AU - Ginardi, C. AU - Zuliani, C. PY - 1998 DA - 1998// TI - Haemostatic abnormalities in lung cancer: prognostic implications JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(96)00310-3 DO - 10.1016/S0959-8049(96)00310-3 ID - Buccheri1998 ER - TY - JOUR AU - Seitz, R. AU - Heidtmann, H. H. AU - Wolf, M. AU - Immel, A. AU - Egbring, R. PY - 1997 DA - 1997// TI - Prognostic impact of an activation of coagulation in lung cancer JO - Ann Oncol VL - 9 UR - https://doi.org/10.1023/A:1008477616923 DO - 10.1023/A:1008477616923 ID - Seitz1997 ER - TY - JOUR AU - Sorensen, H. T. AU - Mellemkjaer, L. AU - Olsen, J. H. AU - Nielsen, G. L. PY - 2000 DA - 2000// TI - Prognosis of cancers associated with venous thromboembolism JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200012213432504 DO - 10.1056/NEJM200012213432504 ID - Sorensen2000 ER - TY - JOUR AU - Lee, A. Y. AU - Levine, M. N. AU - Baker, R. I. AU - Bowden, C. AU - Kakkar, A. K. AU - Prins, M. AU - Rickles, F. R. AU - Julian, J. A. AU - Math, M. AU - Haley, S. AU - Kovacs, M. J. AU - Gent, M. PY - 2003 DA - 2003// TI - Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa025313 DO - 10.1056/NEJMoa025313 ID - Lee2003 ER - TY - JOUR AU - Wolf, R. A. PY - 2003 DA - 2003// TI - Are patients with cancer receiving adequate thromboprophylaxis? results from FRONTLINE JO - Cancer Treat Rev VL - 29 UR - https://doi.org/10.1016/S0305-7372(03)80002-6 DO - 10.1016/S0305-7372(03)80002-6 ID - Wolf2003 ER - TY - JOUR AU - Kirwan, C. C. PY - 2003 DA - 2003// TI - Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7415.597 DO - 10.1136/bmj.327.7415.597 ID - Kirwan2003 ER - TY - JOUR AU - Donati, M. PY - 1995 DA - 1995// TI - Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice JO - Thromb Haemost VL - 74 ID - Donati1995 ER - TY - JOUR AU - Mousa, S. PY - 2002 DA - 2002// TI - Anitcoagulants in thrombosis and cancer: the missing link JO - Semin Thromb Hemost VL - 28 UR - https://doi.org/10.1055/s-2002-20559 DO - 10.1055/s-2002-20559 ID - Mousa2002 ER - TY - JOUR AU - Gouin-Thibault, I. AU - Samama, M. M. PY - 1999 DA - 1999// TI - Laboratory analysis of the thrombophilic state in cancer patients JO - Semin Thromb Hemost VL - 25 UR - https://doi.org/10.1055/s-2007-994918 DO - 10.1055/s-2007-994918 ID - Gouin-Thibault1999 ER - TY - JOUR AU - Falanga, A. AU - Rickles, F. R. PY - 1999 DA - 1999// TI - Pathophysiology of the thrombophilic state in the cancer patient JO - Semin Thromb Hemost VL - 25 UR - https://doi.org/10.1055/s-2007-994919 DO - 10.1055/s-2007-994919 ID - Falanga1999 ER - TY - JOUR AU - Bromberg, M. AU - Capello, M. PY - 1999 DA - 1999// TI - Cancer and blood coagulation: molecular aspects JO - Cancer J Sci Am VL - 5 ID - Bromberg1999 ER - TY - JOUR AU - Zacharski, L. AU - Ornstein, D. PY - 1998 DA - 1998// TI - Heparin and cancer JO - Thromb Haemost VL - 80 ID - Zacharski1998 ER - TY - JOUR AU - Kakkar, A. K. AU - Hedges, A. R. AU - Williamson, R. C. N. AU - Kakkar, V. V. PY - 1995 DA - 1995// TI - Perioperative herparin therapy inhibits late death from metastatic cancer JO - Int J Oncol VL - 6 ID - Kakkar1995 ER - TY - JOUR AU - Lebeau, B. AU - Chastang, C. AU - Brechot, J. M. AU - Capron, F. AU - Dautzenberg, B. AU - Delaisements, C. AU - Mornet, M. AU - Brun, J. AU - Hurdebourcq AU - Lemarie, E. PY - 1994 DA - 1994// TI - Subcutaneous heparin treatment increases survival in small cell lung cancer "Petit Cellules" Group JO - Cancer VL - 74 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Lebeau1994 ER - TY - JOUR AU - Altinbas, M. AU - Coskun, H. S. AU - Er, O. PY - 2004 DA - 2004// TI - A randomised clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer JO - J Thromb Haemost VL - 2 UR - https://doi.org/10.1111/j.1538-7836.2004.00871.x DO - 10.1111/j.1538-7836.2004.00871.x ID - Altinbas2004 ER - TY - JOUR AU - Kakkar, A. K. AU - Levine, M. N. AU - Kadziola, Z. AU - Lemoine, N. R. AU - Low, V. AU - Patel, H. K. AU - Rustin, G. AU - Thomas, M. AU - Quigley, M. AU - Williamson, R. C. N. PY - 2004 DA - 2004// TI - Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.10.002 DO - 10.1200/JCO.2004.10.002 ID - Kakkar2004 ER - TY - JOUR AU - Hejna, M. AU - Raderer, M. AU - Zielinski, C. C. PY - 1999 DA - 1999// TI - Inhibition of metastases by anticoagulants JO - J Nati Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.1.22 DO - 10.1093/jnci/91.1.22 ID - Hejna1999 ER - TY - JOUR AU - Hirsh, J. PY - 1991 DA - 1991// TI - Heparin JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199105303242206 DO - 10.1056/NEJM199105303242206 ID - Hirsh1991 ER - TY - JOUR AU - Iruela-Arispe, M. L. AU - Dvorak, H. F. PY - 1997 DA - 1997// TI - Angiogenesis: a dynamic balance of stimulators and inhibitors JO - Thromb Haemost VL - 78 ID - Iruela-Arispe1997 ER - TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Seminars in medicine of the Beth Israel Hospital in Boston JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199512283332608 DO - 10.1056/NEJM199512283332608 ID - Folkman1995 ER - TY - JOUR AU - Bennett, M. R. AU - Evan, G. I. AU - Newby, A. C. PY - 1994 DA - 1994// TI - Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis JO - Circ Res VL - 74 UR - https://doi.org/10.1161/01.RES.74.3.525 DO - 10.1161/01.RES.74.3.525 ID - Bennett1994 ER - TY - JOUR AU - Wang, A. AU - Templeton, D. M. PY - 1996 DA - 1996// TI - Inhibition of mitogenesis and c-fos induction in mesanglial cells by heparin and heparin sulfates JO - Kidney Int VL - 49 UR - https://doi.org/10.1038/ki.1996.63 DO - 10.1038/ki.1996.63 ID - Wang1996 ER - TY - JOUR AU - Mousa, S. PY - 2002 DA - 2002// TI - The low molecular weight heparin, tinzaparin, in thrombosis and beyond JO - Cardiovasc Drug Rev VL - 20 ID - Mousa2002 ER - TY - JOUR AU - Mousa, A. AU - Mohamed, S. PY - 2004 DA - 2004// TI - Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anticancer efficacy JO - Oncol Rep VL - 12 ID - Mousa2004 ER - TY - JOUR AU - Khorana, A. A. AU - Sahni, A. AU - Altland, O. D. AU - Francis, C. W. PY - 2003 DA - 2003// TI - Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight JO - Arterioscler Thromb Vasc Biol VL - 1 UR - https://doi.org/10.1161/01.ATV.0000090671.56682.D7 DO - 10.1161/01.ATV.0000090671.56682.D7 ID - Khorana2003 ER - TY - JOUR AU - Vlodavsky, I. AU - Ishai-Michaeli, R. AU - Mohsen, M. AU - Bar-Shavit, R. AU - Catane, R. AU - Ekre, H. P. AU - Svahn, C. M. PY - 1992 DA - 1992// TI - Modulation of neovasculaization and metastasis by species of heparin JO - Adv Exp Med Biol VL - 313 UR - https://doi.org/10.1007/978-1-4899-2444-5_31 DO - 10.1007/978-1-4899-2444-5_31 ID - Vlodavsky1992 ER - TY - JOUR AU - Ekre, H. P. AU - Naparstek, Y. AU - Lider, O. AU - Hyden, P. AU - Hagermark, O. AU - Nilsson, T. AU - Vlodavsky, I. AU - Cohen, I. PY - 1992 DA - 1992// TI - Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration JO - Adv Exp Med Biol VL - 313 UR - https://doi.org/10.1007/978-1-4899-2444-5_32 DO - 10.1007/978-1-4899-2444-5_32 ID - Ekre1992 ER - TY - JOUR AU - Bergqvist, D. AU - Burmark, U. S. AU - Flordal, P. A. AU - Frisell, J. AU - Hallbook, T. AU - Hedberg, M. PY - 1995 DA - 1995// TI - Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2,500 versus 5,000 XaI units in 2070 patients JO - Br J Surg VL - 82 UR - https://doi.org/10.1002/bjs.1800820421 DO - 10.1002/bjs.1800820421 ID - Bergqvist1995 ER - TY - JOUR AU - Royston, A. AU - Babiker, A. PY - 2002 DA - 2002// TI - A menu driven facility for complex sample size calculation in randomised controlled trials with a survival or a binary outcome JO - Stata Journal VL - 2 ID - Royston2002 ER - TY - JOUR AU - Dunn, G. AU - Maracy, M. AU - Dowrick, C. AU - Ayuso-Mateos, J. L. AU - Dalgard, O. S. AU - Page, H. AU - Lehtinen, V. PY - 2003 DA - 2003// TI - Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow up JO - British Journal of Psychiatry VL - 183 UR - https://doi.org/10.1192/bjp.183.4.323 DO - 10.1192/bjp.183.4.323 ID - Dunn2003 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/9/355/prepub UR - http://www.biomedcentral.com/1471-2407/9/355/prepub ID - ref43 ER -